Popular Articles

TCT 2009: Interventional Cardiology Treatments And Their Impact On Heart Disease
TCT will also host forum on electronic medical records
generic viagra online
International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells
International Stem Cell Corporation (OTCBB:ISCO), the first company to perfect a method of creating human "parthenogenetic" stem cells from unfertilized eggs, has received positive early results from animal trials designed to improve photorefractive keratectomy (PRK), a form of corrective laser eye surgery that offers an improved alternative to LASIK.
News of the day
Glybera(TM) Shows Long-Term Health Benefits
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today new data showing that a one-time administration of its lead product GlyberaTM results in significant long-term health benefits. Long-term follow-up data from two clinical trials show that one administration with GlyberaTM brings significant and clinically important reduction in acute pancreatitis in lipoprotein lipase deficient patients. Recurrent acute pancreatitis is the most debilitating complication of lipoprotein lipase deficiency (LPLD) and is associated with significant morbidity and mortality. These data were presented at the International Symposium on Atherosclerosis in Boston, one on the most prestigious conferences on arterial disease well-attended by expert physicians.
Nutrition

Medicare Tapped For Savings To Cover Reform Costs, Again

In his weekly Internet and radio address Saturday, President Obama announced a plan to cut $313 billion in Medicare and Medicaid spending over the next decade as a way to raise money for overhauling the health care system and covering millions of the uninsured, the Los Angeles Times reports. The largest savings include "increased efficiencies in the system," cuts to subsidies paid to hospitals for treating the uninsured, cuts to prices the government pays for prescription drugs for seniors. The paper adds: "the proposal -- which includes potential cuts to hospitals, pharmaceutical companies and other providers -- also underscores the political delicacy of the administration"s search for money for a massive healthcare overhaul that could cost more than $1.2 trillion over the next decade" (Levey, 6/15). "The cuts come on top of Medicare and Medicaid revisions Obama requested earlier this year in his fiscal 2010 budget proposal; together with those cuts the White House is now proposing a total of $622 billion in Medicare and Medicaid revisions over 10 years, most of it from Medicare," CQ Politics reports. "White House Budget Director Peter R. Orszag said the cuts Obama identified are a way of showing how an overhaul could be financed while the Senate Finance and House Ways and Means committees write draft bills. Combined with earlier cuts, Orszag said the administration has now identified nearly $950 billion worth of savings," according to CQ (Bettelheim, 6/14). The cuts would knock out over $100 billion in direct subsidies to hospitals, the Wall Street Journal reports. "After agreeing in May to contribute to a $2 trillion reduction in health spending over 10 years, the hospital industry is now bristling at the prospect of more givebacks," the Journal reports. The American Hospital Association said its concerned the administration would point to the cuts before Congress mapped out is plan to expand coverage, which would relieve the need for subsidies (Adamy and Rockoff, 6/15). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):